Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis

Abstract Deep vein thrombosis (DVT) is a clinically significant condition characterized by the formation of thrombi in deep venous structures, leading to high morbidity and potential mortality. Identifying reliable biomarkers for DVT risk prediction remains challenging due to the intricate genetic a...

Full description

Saved in:
Bibliographic Details
Main Authors: Usi Sukorini, Gisca Ajeng Widya Ninggar, Mohammad Hendra Setia Lesmana, Lalu Irham, Wirawan Adikusuma, Hegaria Rahmawati, Nur Imma Fatimah Harahap, Chiou-Feng Lin, Rahmat Dani Satria
Format: Article
Language:English
Published: BioMed Central 2025-05-01
Series:Genomics & Informatics
Subjects:
Online Access:https://doi.org/10.1186/s44342-025-00047-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850272011809456128
author Usi Sukorini
Gisca Ajeng Widya Ninggar
Mohammad Hendra Setia Lesmana
Lalu Irham
Wirawan Adikusuma
Hegaria Rahmawati
Nur Imma Fatimah Harahap
Chiou-Feng Lin
Rahmat Dani Satria
author_facet Usi Sukorini
Gisca Ajeng Widya Ninggar
Mohammad Hendra Setia Lesmana
Lalu Irham
Wirawan Adikusuma
Hegaria Rahmawati
Nur Imma Fatimah Harahap
Chiou-Feng Lin
Rahmat Dani Satria
author_sort Usi Sukorini
collection DOAJ
description Abstract Deep vein thrombosis (DVT) is a clinically significant condition characterized by the formation of thrombi in deep venous structures, leading to high morbidity and potential mortality. Identifying reliable biomarkers for DVT risk prediction remains challenging due to the intricate genetic and molecular mechanisms underlying the disease. This study aims to investigate the best biomarker for DVT. Our study utilized genome-wide association studies (GWAS) findings coupled with a functional annotation scoring system to identify and prioritize genetic markers with strong associations to DVT. Furthermore, gene expression levels were analyzed to determine the most promising genetic markers. Several databases were utilized, including the GWAS Catalog, HaploReg 4.2, WebGestalt, Enrichr, and the GTEx Portal. Through the comprehensive analysis, we found 5 potential biomarkers and highlighted thrombomodulin (THBD) and Factor V (F5) as the best blood-based biomarkers. THBD and F5 genes were selected based on their elevated expression levels in blood and the presence of eQTLs. Functionally, THBD modulates coagulation via protein C activation, while F5 is pivotal in thrombin formation and clot stabilization, underscoring their mechanistic relevance to DVT pathogenesis, and rendering them suitable for non-invasive clinical assessment. Our findings emphasize the potential of genetic biomarkers to transform DVT risk assessment and support advancements in precision medicine for thrombotic disorders.
format Article
id doaj-art-d83f29d23da945cdb4fe3f2318441a2b
institution OA Journals
issn 2234-0742
language English
publishDate 2025-05-01
publisher BioMed Central
record_format Article
series Genomics & Informatics
spelling doaj-art-d83f29d23da945cdb4fe3f2318441a2b2025-08-20T01:51:59ZengBioMed CentralGenomics & Informatics2234-07422025-05-0123111210.1186/s44342-025-00047-2Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosisUsi Sukorini0Gisca Ajeng Widya Ninggar1Mohammad Hendra Setia Lesmana2Lalu Irham3Wirawan Adikusuma4Hegaria Rahmawati5Nur Imma Fatimah Harahap6Chiou-Feng Lin7Rahmat Dani Satria8Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah MadaDepartment of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah MadaDepartment of Nursing, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah MadaFaculty of Pharmacy, Ahmad Dahlan UniversityResearch Center for Computing, Research Organization for Electronics and Informatics, National Research and Innovation Agency (BRINPKU Muhammadiyah HospitalDepartment of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah MadaDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical UniversityDepartment of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah MadaAbstract Deep vein thrombosis (DVT) is a clinically significant condition characterized by the formation of thrombi in deep venous structures, leading to high morbidity and potential mortality. Identifying reliable biomarkers for DVT risk prediction remains challenging due to the intricate genetic and molecular mechanisms underlying the disease. This study aims to investigate the best biomarker for DVT. Our study utilized genome-wide association studies (GWAS) findings coupled with a functional annotation scoring system to identify and prioritize genetic markers with strong associations to DVT. Furthermore, gene expression levels were analyzed to determine the most promising genetic markers. Several databases were utilized, including the GWAS Catalog, HaploReg 4.2, WebGestalt, Enrichr, and the GTEx Portal. Through the comprehensive analysis, we found 5 potential biomarkers and highlighted thrombomodulin (THBD) and Factor V (F5) as the best blood-based biomarkers. THBD and F5 genes were selected based on their elevated expression levels in blood and the presence of eQTLs. Functionally, THBD modulates coagulation via protein C activation, while F5 is pivotal in thrombin formation and clot stabilization, underscoring their mechanistic relevance to DVT pathogenesis, and rendering them suitable for non-invasive clinical assessment. Our findings emphasize the potential of genetic biomarkers to transform DVT risk assessment and support advancements in precision medicine for thrombotic disorders.https://doi.org/10.1186/s44342-025-00047-2Deep vein thrombosisBiomarkersGenome-wide association studiesSingle nucleotide polymorphismsThrombomodulinFactor V
spellingShingle Usi Sukorini
Gisca Ajeng Widya Ninggar
Mohammad Hendra Setia Lesmana
Lalu Irham
Wirawan Adikusuma
Hegaria Rahmawati
Nur Imma Fatimah Harahap
Chiou-Feng Lin
Rahmat Dani Satria
Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis
Genomics & Informatics
Deep vein thrombosis
Biomarkers
Genome-wide association studies
Single nucleotide polymorphisms
Thrombomodulin
Factor V
title Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis
title_full Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis
title_fullStr Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis
title_full_unstemmed Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis
title_short Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis
title_sort genome wide association study driven identification of thrombomodulin and factor v as the best biomarker combination for deep vein thrombosis
topic Deep vein thrombosis
Biomarkers
Genome-wide association studies
Single nucleotide polymorphisms
Thrombomodulin
Factor V
url https://doi.org/10.1186/s44342-025-00047-2
work_keys_str_mv AT usisukorini genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis
AT giscaajengwidyaninggar genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis
AT mohammadhendrasetialesmana genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis
AT laluirham genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis
AT wirawanadikusuma genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis
AT hegariarahmawati genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis
AT nurimmafatimahharahap genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis
AT chioufenglin genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis
AT rahmatdanisatria genomewideassociationstudydrivenidentificationofthrombomodulinandfactorvasthebestbiomarkercombinationfordeepveinthrombosis